Propapoptotic effects of NF-κB in LNCaP prostate cancer cells lead to serine protease activation

Cell Death and Differentiation

Volumn 9, Issue 9, 2002, Pages 972-980

  Kimura, K ^a   Gelmann, E P ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Apoptosis; Caspase; FAS; NF B; Serine protease; TNF

Indexed keywords

CASPASE 7; CASPASE 8; CASPASE INHIBITOR; ENZYME PRECURSOR; FAS ANTIBODY; FAS ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; SERINE PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL; CELL CLONING; CELL SURFACE; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVATION; ENZYME SUBSTRATE; GAMMA IRRADIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION EXPOSURE; RADIOSENSITIVITY; RADIOSENSITIZATION; REPRESSOR GENE; SENSITIVITY ANALYSIS;

ANTIGENS, CD95; APOPTOSIS; CARCINOMA; CASPASES; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; GAMMA RAYS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; MALE; MUTATION; NF-KAPPA B; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; REPRESSOR PROTEINS; SERINE ENDOPEPTIDASES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036719081     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401049     Document Type: Article

References (56)

1. Radiation inactivation of human prostate cancer cells: The role of apoptosis
2. Apoptosis and cancer: Strategies for integrating programmed cell death
3. Tumor cell survival and resistance to therapy
4. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
5. Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis
6. Tumor Necrosis Factor-alpha and Fas Activate Complementary Fas- associated Death Domain-dependent Pathways That Enhance Apoptosis Induced by gamma-Irradiation
7. Tumor necrosis factor receptor and Fas signaling mechanisms
8. The TNF receptor l-associated protein TRADD signals cell death and NF-kappa B activation
9. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
10. Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase
11. FADD is required for multiple signaling events downstream of the receptor Fas
12. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
13. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB butnotFas/APO-1-initiated apoptosis
14. RIP and FADD: Two 'death domain'-containing proteins can induce apoptosis by convergent, but dissociable, pathways
15. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment
16. RAIDD is a new 'death' adaptor molecule
17. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
18. Tumor necrosis factor alpha activates NF-kappaB in acid sphingomyelinase-deficient mouse embryonic fibroblasts
19. TNF-induced activation of NF-kappa B
20. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
21. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
22. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
23. Control of apoptosis by Rel/NF-kappaB transcription factors
24. Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis
25. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B
26. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB
27. Androgen blocks apoptosis of hormone-dependent prostate cancer cells
28. Synthesis of procaspases-3 and -7 during apoptosis in prostate cancer cells
29. Caspase -7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP
30. Irreversible inhibition of trypsin by TLCK. Acontinuous method for kinetic study of irreversible enzymatic inhibitors in the presence of substrate
31. The site of action of N-alpha-tosyl-L-lysyl-chloromethyl-ketone (TLCK) on cloned cytotoxic T lymphocytes
32. Radiation-induced apoptosis mediated by retinoblastoma protein
33. Thiol modulation of TNF alpha and IL-1 induced MnSOD gene expression and activation of NF-kappa B
34. Interleukin-1 beta induced activation of NF-kappa B in insulin producing RINm5F cells is prevented by the protease inhibitor N alpha-p- tosyl-L-lysine chloromethylketone
35. Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p 105 are obligatory steps in the activation of NF-kappa B
36. Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide
37. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop
38. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis
39. Nuclear factor-kappaB/Rel is apoptogenic in cytokine withdrawal-induced programmed cell death
40. Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum
41. Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum
42. Role of NF-kappaB in p53-mediated programmed cell death
43. NF-kappaB to the rescue: RELs, apoptosis and cellular transformation
44. NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis
45. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases
46. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions
47. Ionizing radiation-induced, Bax-mediated cell death is dependent on activation of cysteine and serine proteases
48. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents
49. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support
50. Identification of the histidine residue at the active center of trypsin labelled by TLCK
51. Cathepsin D targeted by acid sphingomyelinase-derived ceramide
52. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells
53. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells
54. Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase
55. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB
56. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells